Original Research
Published on 11 Dec 2025
Fruquintinib saddles tumor immune tolerance by curbing pro-tumoral immature myeloid cell populations
in Cancer Immunity and Immunotherapy
- 1,518 views
Original Research
Published on 11 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 11 Dec 2025
in Viral Immunology
Clinical Trial
Published on 11 Dec 2025
in Cancer Immunity and Immunotherapy
Review
Published on 11 Dec 2025
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Brief Research Report
Published on 11 Dec 2025
in Vaccines and Molecular Therapeutics
Original Research
Published on 11 Dec 2025
in Immunological Tolerance and Regulation
Original Research
Published on 11 Dec 2025
in T Cell Biology
Case Report
Published on 11 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 10 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 10 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 10 Dec 2025
in Primary Immunodeficiencies
Original Research
Published on 10 Dec 2025
in Cancer Immunity and Immunotherapy
Review
Published on 10 Dec 2025
in Cancer Immunity and Immunotherapy
Perspective
Published on 10 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 10 Dec 2025
in Systems Immunology
Review
Published on 10 Dec 2025
in Cancer Immunity and Immunotherapy
Review
Published on 10 Dec 2025
in Cancer Immunity and Immunotherapy
Review
Published on 10 Dec 2025
in Inflammation
Original Research
Published on 10 Dec 2025
in Cancer Immunity and Immunotherapy
Case Report
Published on 10 Dec 2025
in Cancer Immunity and Immunotherapy
Review
Published on 10 Dec 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Systematic Review
Published on 10 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 10 Dec 2025
in Nutritional Immunology
Correction
Published on 10 Dec 2025
in Systems Immunology